Electromed Inc (ELMD) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Electromed Inc stock (ELMD) is currently trading at $24.70. Electromed Inc PE ratio is 22.60. Electromed Inc PS ratio (Price-to-Sales) is 2.82. Analyst consensus price target for ELMD is $37.00. WallStSmart rates ELMD as Moderate Buy.
- ELMD PE ratio analysis and historical PE chart
- ELMD PS ratio (Price-to-Sales) history and trend
- ELMD intrinsic value — DCF, Graham Number, EPV models
- ELMD stock price prediction 2025 2026 2027 2028 2029 2030
- ELMD fair value vs current price
- ELMD insider transactions and insider buying
- Is ELMD undervalued or overvalued?
- Electromed Inc financial analysis — revenue, earnings, cash flow
- ELMD Piotroski F-Score and Altman Z-Score
- ELMD analyst price target and Smart Rating
Electromed Inc
📊 No data available
Try selecting a different time range
ELMD Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Electromed Inc (ELMD)
ELMD trades at a significant discount to its Graham intrinsic value of $48.20, offering a 48% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Electromed Inc (ELMD) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, return on equity, eps growth. Concerns around market cap. Overall metrics suggest strong investment potential with favorable risk/reward.
Electromed Inc (ELMD) Key Strengths (4)
Growing significantly faster than its price suggests
Earnings per share surging 45.50% year-over-year
Every $100 of equity generates $20 in profit
59.90% held by institutions, strong professional interest
Supporting Valuation Data
Electromed Inc (ELMD) Areas to Watch (6)
Micro-cap company with very limited liquidity and high volatility
Premium pricing at 4.2x book value
Decent operational efficiency, solid but not exceptional
Revenue is fairly priced at 2.82x sales
Solid revenue growth at 16.30% per year
Decent profitability, keeps $13 per $100 revenue
Electromed Inc (ELMD) Detailed Analysis Report
Overall Assessment
This company scores 68/100 in our Smart Analysis, earning a B- grade. Out of 10 metrics analyzed, 4 register as strengths (avg 9.3/10) while 6 fall into concern territory (avg 5.2/10). All four categories (Growth, Profitability, Valuation, and Quality) show healthy scores, indicating broadly sound fundamentals.
The Bull Case
The strongest argument centers on PEG Ratio, EPS Growth, Return on Equity. Valuation metrics including PEG Ratio (0.35) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 20.20%. Growth metrics are encouraging with EPS Growth at 45.50%.
The Bear Case
The primary concerns are Market Cap, Price/Book, Operating Margin. Some valuation metrics including Price/Sales (2.82), Price/Book (4.24) suggest expensive pricing. Growth concerns include Revenue Growth at 16.30%, which may limit upside. Profitability pressure is visible in Operating Margin at 19.20%, Profit Margin at 13.10%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Market Cap improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 20.20% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 16.30% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (PEG Ratio, EPS Growth) and negatives (Market Cap, Price/Book). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ELMD Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ELMD's Price-to-Sales ratio of 2.82x trades at a 43% premium to its historical average of 1.97x (82th percentile). The current valuation is 46% below its historical high of 5.2x set in Jan 2025, and 432% above its historical low of 0.53x in Dec 2012. Over the past 12 months, the PS ratio has compressed from ~3.5x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Electromed Inc (ELMD) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Electromed Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 69M with 16% growth year-over-year. Profit margins of 13.1% are healthy, with room for further expansion as the business scales.
Key Findings
ROE of 20.2% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 3M in free cash flow and 3M in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Margin expansion: can Electromed Inc push profit margins above 15% as the business scales?
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Electromed Inc.
Bottom Line
Electromed Inc offers an attractive blend of growth (16% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Electromed Inc(ELMD)
NYSE MKT
HEALTHCARE
MEDICAL DEVICES
USA
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high-frequency chest wall oscillation (HFCWO) therapy in lung care for patients of all ages in the United States. and internationally. The company is headquartered in New Prague, Minnesota.